doranidazole has been researched along with ku 2285 in 1 studies
| Studies (doranidazole) | Trials (doranidazole) | Recent Studies (post-2010) (doranidazole) | Studies (ku 2285) | Trials (ku 2285) | Recent Studies (post-2010) (ku 2285) |
|---|---|---|---|---|---|
| 30 | 4 | 10 | 19 | 2 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, M; Ogino, H; Shibamoto, Y; Sugie, C | 1 |
1 review(s) available for doranidazole and ku 2285
| Article | Year |
|---|---|
The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs.
Topics: Asian People; Cell Hypoxia; Clinical Trials as Topic; Humans; Imidazoles; Neoplasms; Nitroimidazoles; Prodrugs; Radiation; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 2004 |